Omega Therapeutics, Inc. (OMGA)

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.

Address

140 FIRST STREET, SUITE 501
CAMBRIDGE, MA 02141

Founded

2016

Number of Employees

94

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)